Premium
Bioassay‐Guided Isolation and Structural Modification of the Anti‐ TB Resorcinols from Ardisia gigantifolia
Author(s) -
Guan YiFu,
Song Xun,
Qiu MingHua,
Luo ShiHong,
Wang BaoJie,
Van Hung Nguyen,
Cuong Nguyen M.,
Soejarto Djaja Doel,
Fong Harry H.S.,
Franzblau Scott G.,
Li ShengHong,
He ZhenDan,
Zhang HongJie
Publication year - 2016
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.12756
Subject(s) - resorcinol , bioassay , mycobacterium tuberculosis , chemistry , lead compound , potency , stereochemistry , isolation (microbiology) , tuberculosis , biology , microbiology and biotechnology , in vitro , biochemistry , organic chemistry , medicine , genetics , pathology
Tuberculosis ( TB ) is a highly contagious disease mainly caused by Mycobacterium tuberculosis H 37 R V . Antitubercular (anti‐ TB ) bioassay‐guided isolation of the CHC l 3 extract of the leaves and stems of the medicinal plant Ardisia gigantifolia led to the isolation of two anti‐ TB 5‐alkylresorcinols, 5‐(8 Z ‐heptadecenyl) resorcinol ( 1 ) and 5‐(8 Z ‐pentadecenyl) resorcinol ( 2 ). We further synthesized 15 derivatives based on these two natural products. These compounds (natural and synthetic) were evaluated for their anti‐ TB activity against Mycobacterium tuberculosis H 37 R V . Resorcinols 1 and 2 exhibited anti‐ TB activity with MIC values at 34.4 and 79.2 μ m in MABA assay, respectively, and 91.7 and 168.3 μ m in LORA assay, respectively. Among these derivatives, compound 8 was found to show improved anti‐ TB activity than its synthetic precursor ( 2 ) with MIC values at 42.0 μ m in MABA assay and 100.2 μ m in LORA assay. The active compounds should be regarded as new hits for further study as a novel class of anti‐ TB agents. The distinct structure–activity correlations of the parent compound were elucidated based on these derivatives.